デフォルト表紙
市場調査レポート
商品コード
1212475

医療用外骨格の世界市場

Medical Exoskeleton

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 89 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
医療用外骨格の世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

医療用外骨格の世界市場は2030年までに58億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に9億5,500万米ドルと推定される医療用外骨格の世界市場は、2022年から2030年にかけてCAGR 25.2%で成長し、2030年には改訂58億米ドルに到達すると予測されます。本レポートで分析したセグメントの一つであるハードウェアは、CAGR22.3%を記録し、分析期間終了時には28億米ドルに達すると予測されます。パンデミック後の回復を考慮し、ソフトウェア分野の成長は、今後8年間のCAGRが28.7%に修正されます。

米国市場は2億9,600万米ドル、中国はCAGR23.5%の成長予測

米国の医療用外骨格市場は、2022年に2億9,600万米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが23.5%となり、2030年には9億1,410万米ドルの市場規模に達すると予測されます。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ22.6%と21.1%の成長が予測されています。欧州では、ドイツがCAGR15.2%で成長すると予測されています。

調査対象企業の例

  • Bionik Laboratories Corp
  • B-TEMIA Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • ExoAtlet
  • Gogoa Mobility Robots SL
  • Hocoma AG(A Subsidiary of DIH Technologies)
  • Parker Hannifin Corp
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • US Bionics
  • Wearable Robotics SRL

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP22233

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Medical Exoskeleton Market to Reach $5.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Medical Exoskeleton estimated at US$955 Million in the year 2022, is projected to reach a revised size of US$5.8 Billion by 2030, growing at aCAGR of 25.2% over the period 2022-2030. Hardware, one of the segments analyzed in the report, is projected to record 22.3% CAGR and reach US$2.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Software segment is readjusted to a revised 28.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $296 Million, While China is Forecast to Grow at 23.5% CAGR

The Medical Exoskeleton market in the U.S. is estimated at US$296 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$914.1 Million by the year 2030 trailing a CAGR of 23.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 22.6% and 21.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.

Select Competitors (Total 34 Featured):

  • Bionik Laboratories Corp
  • B-TEMIA Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • ExoAtlet
  • Gogoa Mobility Robots SL
  • Hocoma AG (A Subsidiary of DIH Technologies)
  • Parker Hannifin Corp
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • US Bionics
  • Wearable Robotics SRL

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Medical Exoskeleton - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Powered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Mobile by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 21: World 18-Year Perspective for Stationary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 22: World Medical Exoskeleton Market Analysis of Annual Sales in US$ for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 25: USA 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 28: USA 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 31: USA 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 34: Canada 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 37: Canada 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 40: Canada 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • JAPAN
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 43: Japan 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 46: Japan 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 49: Japan 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • CHINA
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 52: China 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 55: China 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 58: China 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • EUROPE
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 61: Europe 18-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 64: Europe 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 67: Europe 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 70: Europe 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • FRANCE
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 73: France 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 76: France 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 79: France 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • GERMANY
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 82: Germany 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 85: Germany 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 88: Germany 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 91: Italy 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 94: Italy 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 97: Italy 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 100: UK 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 103: UK 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 106: UK 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 109: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 112: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 115: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 118: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 121: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 124: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • REST OF WORLD
    • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of World Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 127: Rest of World 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 130: Rest of World 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 133: Rest of World 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030

IV. COMPETITION